Merus NV (MRUS)
96.77
+0.41
(+0.43%)
USD |
NASDAQ |
Dec 10, 16:00
96.78
+0.02
(+0.02%)
After-Hours: 20:00
Merus Shareholders Equity (Quarterly): 774.93M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Genmab A/S | 5.751B |
| uniQure NV | 228.75M |
| ProQR Therapeutics NV | 67.06M |
| argenx SE | -- |
| Pharming Group NV | 264.64M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 904.20M |
| Total Liabilities (Quarterly) | 129.26M |
| Debt to Equity Ratio | 0.0159 |
| Current Ratio | 7.972 |
| Net Debt Paydown Yield | -0.00% |